Abstract
The case for universal boosters is weak, and the benefits are unclear.
Original language | English |
---|---|
Article number | n2320 |
Number of pages | 2 |
Journal | BMJ |
Volume | 374 |
DOIs | |
Publication status | E-pub ahead of print - 23 Sept 2021 |
Keywords
- COVID-19
Jake Scott, Aaron Richterman, Muge Cevik*
Research output: Contribution to journal › Editorial
Original language | English |
---|---|
Article number | n2320 |
Number of pages | 2 |
Journal | BMJ |
Volume | 374 |
DOIs | |
Publication status | E-pub ahead of print - 23 Sept 2021 |